Ind-Swift Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹15.16Prev. Close
₹14.85Turnover(Lac.)
₹101.67Day's High
₹17.82Day's Low
₹15.1552 Week's High
₹19.952 Week's Low
₹12Book Value
₹-75.21Face Value
₹2Mkt Cap (₹ Cr.)
85.36P/E
10.9EPS
1.44Divi. Yield
02 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
31 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
20 Jan 2025
12:00 AM
EGM
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 10.83 | 10.83 | 10.83 | 10.83 |
Preference Capital | 14.2 | 14.2 | 14.2 | 14.2 |
Reserves | -701.66 | -715.53 | -731.15 | -706 |
Net Worth | -676.63 | -690.5 | -706.12 | -680.97 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 356.05 | 329.52 | 269.81 | 263.05 |
yoy growth (%) | 8.05 | 22.12 | 2.56 | -14.52 |
Raw materials | -186.52 | -186.89 | -154.15 | -166.02 |
As % of sales | 52.38 | 56.71 | 57.13 | 63.11 |
Employee costs | -55.79 | -52.52 | -48.26 | -42.38 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -28.28 | -23.06 | -25.22 | -103.76 |
Depreciation | -32.7 | -33.59 | -34.63 | -35.73 |
Tax paid | -0.32 | -2.46 | -0.75 | -0.89 |
Working capital | -9.72 | -14.89 | -20.1 | -383.71 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 8.05 | 22.12 | 2.56 | -14.52 |
Op profit growth | 77.3 | 270.66 | -109.62 | -58.33 |
EBIT growth | 219.15 | -130.93 | -79.22 | -51.62 |
Net profit growth | 55.93 | -64.67 | -85.14 | 82.18 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2018 |
|---|---|---|---|---|---|
Gross Sales | 515.23 | 502.25 | 410.96 | 397.71 | 270.57 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 515.23 | 502.25 | 410.96 | 397.71 | 270.57 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 327.58 | 57.65 | 72.43 | 24.28 | 10.16 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,654.9 | 94.41 | 4,12,049.79 | 705.44 | 0.93 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,116.5 | 61.48 | 1,58,156.89 | 598 | 0.5 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,155.2 | 62.03 | 1,38,530.8 | 577 | 0.15 | 2,547 | 249.82 |
Lupin Ltd LUPIN | 2,333.8 | 18.98 | 1,04,975.18 | 717.45 | 0.52 | 4,433.96 | 595.49 |
Dr Reddys Laboratories Ltd DRREDDY | 1,232.2 | 21.81 | 1,01,189.64 | 90.6 | 0.66 | 4,266.4 | 377.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & Chief Executive Officer
G Munjal
Executive Chairman
S R Mehta
Joint Managing Director
V R Mehta
Non-Executive & Non-Independent Director
Himanshu Jain
Non-Executive & Non-Independent Director
N R Munjal
Non-Executive & Non-Independent Director
Rishav Mehta
Non Executive & Independent Director
Subhash Chander Galhotra
Non Executive & Independent Director
Anoop Michra
Non Executive & Independent Director
Jagvir Singh Ahluwalia
Non Executive & Independent Director
Bhupinder Singh
Non Executive & Independent Director
Subodh Gupta
Non Executive & Independent Director
Prabhat Khurana
781 Industrial Area Phase-II,
Ram Darbar,
Chandigarh - 160002
Tel: 91-0172-2638781-786
Website: http://www.indswiftltd.com
Email: companysec@indswift.com
Alankit House,
Alankit Heights, 4E/2, Jhandewalan Ex,
New Delhi - 110055
Tel: 91-11-4254 1956
Website: www.alankit.com
Email: info@alankit.com,rta@alankit.com
Summary
Ind-Swift Limited (ISL) is an India-based pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical finished dosage. The products manufactured by the company ...
Read More
Reports by Ind-Swift Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.